Skip to main content
Clinical Trials/NCT00662623
NCT00662623CompletedPhase 2

Enabling Sleep Apnea Patient-Centered Care Via an Internet Intervention

Veterans Medical Research Foundation2 sites in 1 country200 target enrollmentStarted: April 1, 2008Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
200
Locations
2
Primary Endpoint
CPAP Adherence

Study Overview

Brief Summary

The purpose of this study is to examine the effect of different methods of providing education about sleep apnea and continuous positive airway pressure therapy (CPAP) use and how that education might help to improve health outcomes and the amount of time CPAP is used.

Detailed Description

Poor treatment adherence with CPAP therapy is well-documented. Set against a backdrop of telemedicine applications that have grown as fast in unsubstantiated claims and assumptions of patient satisfaction, diagnostic accuracy, clinical efficacy, and cost-effectiveness as they have in technological sophistication and capabilities, the evaluative aspect of this proposal is designed as as a randomized, controlled clinical trial-Usual Care patients (control) versus i-PAP patients (intervention). An important empirical-methodological advantage of the project is the objective measurement of CPAP adherence, which is measured by internal microprocessor as the "amount of time CPAP is used at the prescribed pressure." This objective measurement allows feedback of treatment adherence and efficacy to both patient and provider, and the i-PAP intervention was designed around this central feature.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • age > 18 years
  • confirmed diagnosis of OSA
  • being newly prescribed CPAP therapy
  • having chronic symptoms as noted on screening symptom checklist
  • fluency in English

Exclusion Criteria

  • cognitive impairment sufficient to cause inability to complete the protocol (MMSE < 24/30)
  • residence in a geographical area outside of San Diego County
  • fatal comorbidity (life expectancy less than 6 months as indicated by treating physician)
  • significant documented substance/chemical abuse or other participant circumstances that, in the opinion of a consensus of study team, would interfere with the safety of a prospective participant or their need for treatment

Outcomes

Primary Outcomes

CPAP Adherence

Time Frame: 4 months

Secondary Outcomes

  • Quality of patient-centered collaborative care(4 months)

Investigators

Sponsor
Veterans Medical Research Foundation
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Carl J. Stepnowsky

Study PI

Veterans Medical Research Foundation

Study Sites (2)

Loading locations...

Similar Trials